Table 2.
HCV Antibody and HCV RNA–Positive (n = 13) | HCV Antibody and HCV RNA–Negative (n = 12) | Healthy Controls (n = 18) | Statistic | P Value | |
---|---|---|---|---|---|
Age (years ± SD) | 35.59 ± 11.75 | 38.83 ± 7.99 | 48.46 ± 15.70 | Kruskal-Wallis test | 0.06 |
Lobular activity (0–4) | 2.08 ± 0.29 | 1.75 ± 0.62 | — | Mann–Whitney U test | 0.11 |
Portal activity (0–4) | 2.00 ± 0.60 | 1.83 ± 0.58 | — | ″ | 0.49 |
Fibrosis (0–6) | 1.75 ± 0.75 | 1.92 ± 1.24 | — | ″ | 0.69 |
Interface hepatitis (0–4) | 1.50 ± 0.5 | 0.83 ± 0.72 | — | ″ | 0.03 |
Steatosis (0–3) | 1.17 ± 0.94 | 0.58 ± 0.79 | — | ″ | 0.11 |